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Mammalian Sterile 20 (Ste20)-like kinase 3 (MST3)
is a ubiquitously expressed kinase capable of
enhancing axon outgrowth. Whether and how MST3
kinase signaling might regulate development of
dendritic filopodia and spine synapses is unknown.
Through shRNA-mediated depletion of MST3 and
kinase-dead MST3 expression in developing hippo-
campal cultures, we found that MST3 is necessary
for proper filopodia, dendritic spine, and excitatory
synapse development. Knockdown of MST3 in layer
2/3 pyramidal neurons via in utero electroporation
also reduced spine density in vivo. Using chemical
genetics, we discovered thirteen candidate MST3
substrates and identified the phosphorylation sites.
Among the identified MST3 substrates, TAO kinases
regulate dendritic filopodia and spine development,
similar to MST3. Furthermore, using stable isotope
labeling by amino acids in culture (SILAC), we show
that phosphorylated TAO1/2 associates with Myosin
Va and is necessary for its dendritic localization, thus
revealing a mechanism for excitatory synapse devel-
opment in the mammalian CNS.
INTRODUCTION
Dendrite arborization and synapse formation are critical for wir-
ing the neural circuitry (Jan and Jan, 2010; Parrish et al., 2006).
Dendrites of pyramidal neurons, the predominant excitatory
neurons in the mammalian brain, contain dendritic spines,
postsynaptic structures harboring more than 90% of excitatory
synapses in the brain (Harris and Kater, 1994; Nimchinsky
et al., 2002). Dendritic spine formation is preceded by actin-
rich filopodia that typically contain immature synapses and are
thought to be involved in dendrite arborization and synaptogen-968 Neuron 84, 968–982, December 3, 2014 ª2014 Elsevier Inc.esis (Fiala et al., 1998; Yuste and Bonhoeffer, 2004). Unraveling
the molecular mechanisms underlying spine formation is an
important research area. Alterations in many proteins impli-
cated in neural development have been linked to neurological
disorders, such as autism (Huguet et al., 2013). A better under-
standing of the molecular mechanisms involved in brain devel-
opment and synapse formation could enable future therapeutic
interventions.
Protein kinases regulate a wide range of cellular processes by
phosphorylating and altering the function of their target mole-
cules. There are more than 500 kinases in the human genome.
How various kinases regulate neuronal development remains
poorly understood. Previous studies by us and others have
revealed that the kinase cascade of the Hippo, Wts, and Trc
(mammalian nuclear Dbf2-related [NDR] 1/2) kinases play impor-
tant and evolutionarily conserved roles in dendrite morphogen-
esis (Emoto et al., 2004, 2006; Gallegos and Bargmann, 2004;
Ultanir et al., 2012; Zallen et al., 2000).
Mammalian Sterile 20 (Ste20)-like kinase 3 (MST3) belongs to
the highly conserved family of Ste20-like kinases that includes
Hippo as the most well studied member. MST3, also known as
Serine/threonine kinase 24, is in the subfamily of the germinal
centre kinase III kinases that contain an 275 amino acids
long N-terminal kinase domain and a C-terminal regulatory
domain. Originally identified as a kinase with requirement of
manganese as a preferred cofactor (Schinkmann and Blenis,
1997), MST3 is predominantly localized to the cytoplasm (Prei-
singer et al., 2004; Schinkmann and Blenis, 1997). MST3a
is the shorter 431 amino acid isoform, which differs from the
443 amino acid MST3b in its 16 N-terminal amino acids. MST3
activation can result from autophosphorylation of a threonine in
the N-terminal kinase domain (Schinkmann and Blenis, 1997),
dephosphorylation of a threonine in the C-terminal regulatory
domain to enable binding of the scaffolding protein MO25 (Fuller
et al., 2012), or caspase mediated cleavage between these two
domains, leading to nuclear localization of the kinase domain
(Huang et al., 2002).
MST3 is expressed ubiquitously in various tissues including
the brain (Irwin et al., 2006; Schinkmann and Blenis, 1997).
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MST3 Phosphorylates TAO1/2 for Spine FormationMST3 signaling is involved in hypoxia-induced apoptosis in tro-
phoblasts, where MST3 can activate Caspase 3 (Wu et al., 2008,
2011). MST3b was isolated as a purine-sensitive kinase, which
facilitates axon outgrowth in response to inosine (Irwin et al.,
2006). MST3b also facilitates axon regeneration in cultures and
in vivo (Lorber et al., 2009), and MST3 is required for radial
neuronal migration in the developing cortex (Tang et al., 2014).
It is unknown whether MST3 plays a role in dendrites, dendritic
filopodia, and spine morphogenesis. MST30s mechanism of
action is also an open question.
The homology of MST3 to the Hippo kinase in Drosophila
prompted us to test whether MST3 signaling has a role in
mammalian dendrite development. By inhibiting MST3 activity
via expression of a kinase-dead form of MST3 or small hairpin
(sh)RNA mediated knockdown of MST3 in dissociated hippo-
campal neuronal cultures, we show that MST3 is required for
the formation and maintenance of dendritic architecture. We
found that MST3 limits dendritic filopodia and facilitates the
formation of spines harboring mature synapses. In utero elec-
troporation of MST3 shRNA also confirmed that MST3 is
required for dendritic spine morphogenesis in vivo. In order
to investigate the molecular mechanisms by which MST3
regulates dendritic architecture, we used chemical genetics
and mass spectrometry and identified 13 potential substrates
of MST3. Next, by expressing phospho mutant and phospho-
mimetic forms of a subset of these novel substrates, we found
that expression of phospho mutant TAO1 or TAO2, or shRNA
mediated knockdown of TAO1/2, is sufficient to cause
increased dendritic filopodia and loss of spines, reminiscent
of MST3 loss of function phenotype. We further show that
downstream of TAO1/2, a Myosin Va complex specifically
binds to the critical phosphorylation site found on both
TAO1 and TAO2. Thus, MST3 kinase functions in the forma-
tion of dendritic spines by regulating several downstream
effectors. In particular, MST30s phosphorylation of TAO1/2,
an autism spectrum disorder susceptibility gene, is critical
for its regulation of Myosin Va dependent trafficking in
dendrites.
RESULTS
MST3 Limits Filopodia on Developing Dendrites
Localization of endogenous MST3 in punctate structures in the
neuronal soma and dendrites was evident from immunofluores-
cence staining of dissociated hippocampal neurons double
labeled with the dendrite marker microtubule-associated protein
2 (MAP2) (Figure 1A), as well as immunofluorescence staining of
GFP transfected neurons in high density cultures with mono-
clonal antibody against MST3 (Figure 1B). The immunofluores-
cence staining was dramatically reduced by shRNA knockdown
of MST3, indicating the staining is specific to MST3 kinase (Fig-
ures S1A and S1B available online). Similar cytoplasmic distribu-
tion of Hemagglutinin (HA)-tagged MST3 proteins expressed in
hippocampal neurons could be detected by anti-HA immunocy-
tochemistry (Figure S1G).
To find out if MST3 is required for postnatal dendritic develop-
ment, we transfected neurons at 3 days in vitro (DIV3) with GFP
plasmid alone as control, or a plasmid with GFP and MST3shRNA expressed via separate promoters, or mutant MST3
and GFP expressing plasmids. GFP expressing control neurons
at DIV7 displayed dendritic filopodia (Figure 1C). Inhibiting MST3
function by expressing either MST3 shRNA orMST3 kinase dead
(K53R) mutant (MST3-KD) together with GFP resulted in a dra-
matic increase in the total dendritic filopodia length per 50 mm
dendrite and filopodia density (Figures 1C and 1D), as well as
average filopodia length (Figure S1C). As expected for effects
due to loss of MST3 function, these phenotypes could be
rescued by coexpressing MST3 shRNA with shRNA-resistant
MST3 (MST3*) (Figures 1C, 1D, and S1C), and they could be pro-
duced by two different MST3 shRNAs (Figure S1H) that effec-
tively knocked down endogenous MST3 (Figures S1F and
S4F), but not by expression of MST3* or a control shRNA (Fig-
ures S1D and S1E). It is conceivable that MST3-KD might be
acting as a dominant-negative form for MST3 function via bind-
ing and titrating coactivators. These data indicate that MST3
is required in developing dendrites to limit dendritic filopodia
formation during early postnatal development.
MST3 Is Required for Spine Formation and Maintenance
To test if MST3 is also required later in development for the
formation or maintenance of dendritic spines, we transfected
neurons with shRNA constructs at DIV16 when spine formation
has largely taken place, and observed spines at DIV20. MST3
shRNA expression resulted in a robust reduction of dendritic
spines and an increase in dendritic filopodia, which could
be rescued by expressing MST3* (Figures 2A and 2B).
Moreover, coexpression of MST3 shRNA together with the
postsynaptic marker PSD-95-GFP and Td-tomato led to a
reduction of the density of PSD-95-GFP containing dendritic
protrusions (Figures 2C and 2D), while total PSD-95-GFP
intensity in dendrites and spines remained constant (data not
shown). The density of dendritic protrusions that colocalized
with endogenous synapsin or PSD-95 was reduced in MST3
shRNA expressing neurons as well (Figures S2A and S2B).
These data indicate that MST3 is required for maintaining
the structure of dendritic spines and excitatory synapses in
cultures.
To test whether MST3 alters spine morphogenesis in vivo, we
expressed MST3 shRNA in developing layer 2/3 cortical neu-
rons in mice via in utero electroporation at embryonic day (E)
14.5 in mice (Figure 2E). We found no change in spine head
diameter (Figure 2G), but a significant reduction in spine density
in MST3 shRNA expressing neurons compared to control neu-
rons expressing GFP alone (Figures 2E and 2F). Taken together,
these findings indicate MST3 kinase signaling is important
for the formation and maintenance of spines and excitatory
synapses.
Identification of MST3 Phosphorylation Substrates
Using Chemical Genetics
To identify downstream effectors of MST3, we used a chemical
genetic method for kinase substrate identification (Blethrow
et al., 2004; Hertz et al., 2010) used previously to identify the
substrates of NDR 1/2 (Ultanir et al., 2012). We generated
two ATP-analog sensitive MST3 mutants, MST3 M99G and
MST3 M99A, by mutating the ‘‘gatekeeper’’ residue at theNeuron 84, 968–982, December 3, 2014 ª2014 Elsevier Inc. 969
Figure 1. MST3 Is Required for Limiting Dendritic Filopodia in Hippocampal Cultures
(A) Image shows MAP2 and MST3 immunostaining of a DIV16 hippocampal neuron; MST3 is found in the cell body and dendrites. Scale bar represents
10 mm.
(B) Hippocampal cultures are transfected with GFP and immunostained with a monoclonal MST3 antibody generated in mouse. Scale bar represents 25 mm.
(C) Representative images of GFP expressing hippocampal neuron dendrites at DIV7. Confocal stacks were obtained and projected at maximum intensity. Scale
bar represents 7.5 mm.
(D) MST3 shRNA andMST3 KD expression leads to increased filopodia length per 50 mmof dendrite and filopodia density, and shRNA effects can be rescuedwith
shRNA resistant MST3 (MST3*) (N = 14, 15, 11, and 6, respectively in columns in graphs). In all figures * = p < 0.05, ** = p < 0.01, and *** = p < 0.001, in Student’s
t test. All error bars reflect SEM. See also Figure S1.
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logs (Blethrow et al., 2004). In order to determine if the MST3
analog-sensitive mutants can utilize a bulky ATP analog with
high efficiency, we used the autophosphorylation activity of
MST3 as a readout in kinase assays using ATP-g-S, Benzyl-
ATP-g-S, Furfuryl-ATP-g-S, or Phenyl-Ethyl-ATP-g-S (Fig-
ure 3A). Thiophosphorylated substrate, in this case MST3 itself,
was alkylated by p-nitrobenzylmesylate (PNBM) for detection
via an anti-thiophosphate ester antibody (Allen et al., 2007).
Because the MST3 M99G analog sensitive kinase was active
with a preference toward Benzyl-ATP-g-S, we used this com-
bination to phosphorylate and then detect MST3 substrates
present in the brain.
To undertake covalent capture for kinase substrate identifica-
tion (Blethrow et al., 2008; Hengeveld et al., 2012; Ultanir et al.,
2012) (Figure 3B), we purified HA tagged MST3 M99G and
MST3-KD that were expressed in COS-7 cells via immunopre-
cipitation using HA antibody bound-beads (Figure S3A) and970 Neuron 84, 968–982, December 3, 2014 ª2014 Elsevier Inc.labeled brain lysates from postnatal day (P) 8–9 mice with
Benzyl-ATP-g-S, with or without MST3 M99G or MST3-KD, for
1–2 hr at 30C. For purification of thiophosphorylated peptide
fragments of potential MST3 targets using the three-step
covalent capture protocol, (1) proteins in the brain lysate
were digested into tryptic fragments, (2) Thiol containing
peptides (including those containing cysteine amino acids)
were captured onto iodoacetyl agarose beads, and (3) thiophos-
phate ester linked peptides were released from the beads by an
oxone induced hydrolysis reaction as phospho-peptides, while
cysteine linked peptides remained on beads. Eluted peptides
and phosphorylation sites were identified in liquid chromatog-
raphy/tandem mass spectrometry analysis. Phospho-peptides
detected more than once in MST3 M99G experimental samples
and not in any of the negative controls are included in a list of
candidates (Figure 3B). Examples of mass spectra for identified
MST3 substrates TAO1 (Figure 3C), EPS8, and TAO2 (Figures
S3B and S3C) are shown.
Figure 2. MST3 Is Required for Spine Development in Hippocampal Cultures and In Vivo
(A) Hippocampal neurons were transfected at DIV16 and imaged at DIV20. Scale bar represents 7.5 mm.
(B) Filopodia density is increased and spine density is reduced in MST3 shRNA expressing neurons. The effect was rescued with shRNA resistant MST3*
expression (n of cells = 11, 12, and 6, respectively).
(C and D) Hippocampal neurons were transfected with PSD-95-GFP and Td-tomato alone or Td-tomato together with MST3 shRNA at DIV13 and fixed and
imaged at DIV16. Density of protrusions containing PSD-95-GFP puncta is reduced in MST3 shRNA expressing neurons (n of cells = 5 for each condition).
Arrows point to filopodia that do not contain PSD-95. Scale bar represents 5 mm. E. MST3 shRNA or GFP alone is expressed in layer 2/3 neurons via in utero
electroporations at E14.5. Brain sections are analyzed at P20. Representative basal dendrite images of layer 2/3 neurons expressing GFP. Scale bar rep-
resents 3 mm.
(F and G) Spine density is reduced and spine head diameter is not changed in MST3 shRNA expressing neurons’ basal dendrites (n of cells = 2 and 7,
respectively). All error bars reflect SEM. See also Figure S2.
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Cytoskeleton Regulators
Of 13 potential MST3 substrates identified along with
their phosphorylation sites (Table 1), tubulin polymerization-
promoting protein (TPPP) and Ermin are specific to oligoden-
drocytes (Brockschnieder et al., 2006; Song et al., 2007),
and the other 11 proteins are potential neuronal targets,including EPS8, an actin capping protein; TAO1 and TAO2,
microtubule and actin interactor binding proteins; FMNL2,
an actin binding protein, Arhgap8, a Rho-GTPase activator;
and GIPC and Tsg101 that function in vesicle trafficking.
Another candidate MST3 substrate is Caspase 3 involved
in the elimination of synapses in neurons (D’Amelio et al.,
2012).Neuron 84, 968–982, December 3, 2014 ª2014 Elsevier Inc. 971
Figure 3. MST3 Substrate Identification Using Chemical Genetics
(A) MST3-MG can use Benzyl-ATP-gS to autophosphorylate. HA tagged
MST3 wt, KD, and analog sensitive mutants (MG and MA) purified from
HEK293 cells and subjected to kinase assay using ATP-g-S analogs.
Autophosphorylation of HA-MST3 is used as a readout of MST3 activity
in kinase assays conducted with various ATP-g-S analogs: Benzyl-ATP-
g-S (Bn), Furfuryl-ATP-g-S (Ff), and Phenyl-ethyl-ATP-g-S (Phe). Total
MST3 levels are shown by anti-HA blot. MST3 M99G can use Bn efficiently.
Kinase assay is detected using PNBM alkylation and anti-thiophosphate
ester blot.
(B) Simplified scheme of kinase substrate labeling and identification (Hertz
et al., 2010).
(C) MS spectra shows the detected phosphopeptide that belongs to the
substrate TAO1. See also Figure S3.
Table 1. Putative MST3 Substrates Are Listed
Candidate
# /4
Exps Phosphorylation Site Function
1 EPS8 3 T317 PGEaGVLT*LaRa actin capping
2 TAO1 2 T440 NREaHFAT*IaRa microtubule
stability
3 TAO2 2 T475 NREaHFAT*IaRa dendrite and
spine development
4 FMNL2 2 T202 SALRYNT*LaP actin bundle
formation
5 Arhgap18 3 T156 VETVSQT*LaRa actin regulation
via Rho GTPase
6 Pak6 3 T99 SVISSNT*IaRa rhoGTPase effector
7 GIPC 2 T242 LGTGRGT*LaRa NMDA receptor
trafficking
8 EF1A1 3 T432 VRDaMRQT*VaA translation
elongation
9 Caspase-3 2 T20 NNFEVKT*IaH synaptic plasticity,
dendrite pruning
10 Tsg101 3 T221 GPSRDGT*IaS membrane
transport
11 Cystine
glutamate
transporter
3 T9 SAVSSPT*Va transporter
12 Ermin 2 T257 SYSRYNT*IaS actin regulation
13 TPPP 2 T161 RKPVVAT*IaS microtubule
regulation
The number of times a protein is identified out of four MS experiments is
shown in the third column. Phosphorylated amino acid number and the
phosphorylation sites are shown in the fourth and fifth columns. Brief
descriptions of reported functions of putative substrates are listed in
the last column.
aIndicates the phosphorylation consensus motif that emerged from our
screen.
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MST3 Phosphorylates TAO1/2 for Spine FormationThis study further uncovered a phosphorylation consensus
sequence for MST3: threonine (as opposed to serine) is the
phosphorylated amino acid followed by Isoleucine, Leucine, or
Valine. In about half of the substrates that we identified, an Argi-972 Neuron 84, 968–982, December 3, 2014 ª2014 Elsevier Inc.nine was found at +2, resulting in a consensus site of T* I/L/V
R for phosphorylation by MST3.
Thousand and One Amino Acid1/2 Phosphorylation by
MST3 Is Important for Limiting Filopodia and
Maintaining Spines
To find out whether some of the putative MST3 substrates
modulate filopodia and spine morphogenesis, we tested phos-
pho mutants and phospho-mimetic mutants of TAO1, GIPC,
ARHGAP18, FMNL2, EPS8, and PAK6 by expressing HA tagged
mutant substrates in hippocampal neurons at DIV3, confirming
their expression by HA immunostaining (Figure S4A) and as-
sessing filopodia phenotypes at DIV7–8. Of the six substrates
tested, the EPS8 phospho-mimetic form (T317D) caused reduc-
tion of filopodia density, while the TAO1 phospho mutant
(T440A or TAO1A) increased filopodia density per dendrite
length and total filopodia length per 50 mm dendrite, similar to
the loss of function of MST3 phenotype (Figures 4A, 4B, and
S4B). The TAO1 T440D mutant (TAO1D) or wild-type TAO1
expression did not alter filopodia structure or density (Figures
4A, S4B, and S4C). While this experiment does not rule out roles
of other identified downstream effectors, it shows that TAO1
Figure 4. Effects of Phosphomutant and Phosphomimetic Substrate Expression on Dendritic Filopodia in Hippocampal Neurons
(A) There were six putative MST3 substrates TAO1, GIPC, ArhGAP18, FMNL2, EPS8, and PAK6 that were mutated at their MST3 phosphorylation site to produce
phosphomutant (T > A, e.g., TAO1A) or phosphomimetic (T > D, e.g., TAO1D) mutants. Filopodia density is measured in neurons transfected at DIV3 and imaged
at DIV7 (For left graph n = 6, 6, 6, 6, 5, 4, and 5 cells, for right graph n = 6, 8, 6, 8, 9, 5, and 5 cells, respectively).
(B) Representative examples of dendrites of neurons expressing GFP alone and GFP and TAO1A mutant. Scale bar represents 2.5 mm.
(C) Representative images of dendrite expressing GFP alone and GFP and TAO1/2 shRNA. Scale bar represents 2.5 mm.
(D) TAO1/2 shRNA and TAO2A significantly increases filopodia length per 50 mm of dendrite (n = 14, 14, and 6 cells, respectively).
(E) Increase in filopodia by TAO1/2 shRNA can be rescued by TAO1* resistant to TAO1/2 shRNA (n = 7, 9, and 9 cells, respectively).
(F) Total filopodia length per 50 mmdendrite is increased inMST3 shRNA and TAO1/2 shRNA expressing neurons.MST3 and TAO1/2 shRNA knockdown together
does not further increase filopodia (n = 5, 7, 8, and 8 cells, respectively).
(G) Images of dendritic spines of neurons transfected with GFP, TAO1/2 shRNA, and TAO1/2 shRNA cotransfected with human TAO2 construct, which is
insensitive to this shRNA, are shown. Scale bar represents 3 mm.
(H) Dendritic filopodia density is increased and spine density is reduced significantly upon TAO1/2 knockdown. The effect was mitigated by expression of human
TAO2 together with TAO1/2 shRNA (n = 10, 10, and 9 cells, respectively). All error bars reflect SEM. See also Figure S4.
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MST3 Phosphorylates TAO1/2 for Spine Formationand TAO2 kinase phosphorylation by MST3 is critical for limiting
dendritic filopodia.
Next, we tested knockdown of TAO1 or EPS8 by generating
three shRNAs in each case. Expressing shRNAs targeting
TAO1 alone (not TAO2) or EPS8 between DIV3 and DIV7–8 did
not alter filopodia of hippocampal neurons (Figures S4D and
S4E, and data not shown), notwithstanding the ability of EPS8
to limit filopodia (Menna et al., 2013; Stamatakou et al., 2013)
and the effect of the EPS8 phospho-mimetic form in reducing
filopodia density (Figure 4A). It is conceivable that the EPS8
function could be compensated for by other isoforms such as
EPS8L2 and EPS8L3 that also contain the MST3 phosphoryla-
tion site.
A TAO2 targeting shRNA with a one base pair mismatch with
TAO1 knocked down TAO2 together with TAO1 so is referred
to as TAO1/2 shRNA (Figure S4F). Transfection at DIV3 with
TAO1/2 shRNA or TAO2 phospho mutant (T475A) caused a
robust increase at DIV7–8 in dendritic filopodia, similar to the
MST3 loss of function phenotype (Figures 4C, 4D, and S4G),
and this phenotype can be rescued with shRNA-resistant mouse
TAO1* (Figure 4E). There were two additional shRNAs targeting
TAO2 only that did not yield this phenotype (data not shown).
Expression of both MST3 shRNA and TAO1/2 shRNA increased
the total filopodial length per 50 mmdendrite to a similar extent as
MST3 knockdown (Figure 4F), indicating that MST3 and TAO1/2
are acting on the same pathway.
To test for TAO1/2 function in the spine maintenance, we
transfected cultured neurons with TAO1/2 shRNA at DIV16 and
imaged these neurons at DIV20. TAO1/2 shRNA caused a reduc-
tion in dendritic spines and an increase in filopodia, which was
rescued by shRNA-resistant human TAO2 (Figures 4G and 4H).
Expression of PSD-95-GFP with Td-tomato and TAO1/2 shRNA
between DIV13 and DIV16 revealed a reduction in the density
of protrusions containing PSD-95-GFP (Figures S4H and S4I),
implicating TAO1/2 in spine synapse maintenance as well as
filopodia development.
MST3 Is Necessary and Sufficient for Thousand and One
Amino Acid1/2 T440/T475 Phosphorylation
We raised a phospho-specific antibody (pTAO1/2) against the
phosphorylation site T440/T475 on TAO1/TAO2, which is almost
identical in TAO1 and TAO2, cotransfected MST3-HA with wild-
type TAO2 or T475A mutant TAO2 (TAO2A), and found MST3-
dependent phosphorylation of the wild-type, but not mutant
TAO2 (Figure 5A). To test if MST3 is necessary for TAO2
phosphorylation, we transfected human embryonic kidney 293
(HEK293) cells with shRNAs targeting human MST3 along with
wild-type TAO2 or TAO2 T475A mutant. MST3 knockdown
reduced the levels of baseline phosphoTAO1/2, but not total
TAO2 protein (Figure 5B). Similar results were obtained for
TAO1 (data not shown), indicating MST3 is necessary and
sufficient for TAO1/2 phosphorylation.
Next, we transfected hippocampal neurons at DIV13 with con-
trol shRNA or MST3 shRNA and stained these neurons at DIV16
with phosphoTAO1/2 antibody, after verifying its specificity by
showing reduced immunostaining upon TAO1/2 shRNA expres-
sion (Figure S5A). MST3 knockdown reduced phosphoTAO1/2
levels in the soma (Figures 5C and 5D). Immunostaining further974 Neuron 84, 968–982, December 3, 2014 ª2014 Elsevier Inc.indicated thatMST3 phosphorylation of TAO1/2 could take place
in the cell body and/or dendrites (Figure 5E).
Thousand and one amino acid1/2 (TAO1/2) kinases are Ste20-
like kinases implicated in microtubule and actin regulation
(see Discussion). TAO1 and TAO2 are expressed from postnatal
day (P)5 to P15 and then downregulated at P20, although TAO1
expression was still detectable (Figure 5F). We next investigated
their role in spine development in vivo by performing in utero
electroporations at embryonic day (E)14.5 either with GFP
plasmid alone as control or together with MST3 shRNA
or TAO1/2 shRNA, and imaging dendritic spines of perfusion
fixed brains at P20. Similar to MST3 shRNA, TAO1/2 shRNA
caused reduction in dendritic spine density in vivo (Figures 5G
and 5H).
A Myosin-Va Containing Complex Binds Thousand and
One Amino Acid1/2 Phosphorylation Site in a
Phosphorylation Dependent Manner
To test if the phosphorylated TAO1/2 site is involved in phos-
phorylation–dependent protein interaction, we used a peptide
pull-downmethod to identify binding proteins in neuronal lysates
labeled by stable isotope labeling by amino acids in culture
(SILAC) (Spellman et al., 2008; Stephanowitz et al., 2012; Zhang
et al., 2011).
We incubated iodoacetyl agarose beads conjugated with pep-
tides corresponding to the TAO2-T475 phosphorylation site in
either nonphosphorylated or phosphorylated forms (Figure 6A)
with neuronal lysates labeled with medium heavy (Lys4 Arg6)
and heavy (Lys8 Arg10) amino acids, and subjected the proteins
bound to the peptide-coated beads to trypsin digest and mass
spectrometry. The relative abundance of each protein was
calculated based on the median of the medium heavy/heavy
ratios for all peptides identified for that protein. A majority of
proteins associated with both peptide- and phospho-peptide
conjugated beads (diamonds in Figure 6A), whereas a number
of proteins were enriched in the phospho-peptide conjugated
beads. We repeated this experiment by switching the medium
heavy and heavy labels on peptide/phospho-peptide pull-downs
and plotted results from the first and second experiments on the
x and y axis. The numbers represent the base 2 logarithms of the
ratio of medium heavy/heavy forms of each detected protein
(Figure 6B), so that the top left quadrant contains proteins that
are enriched in phospho-peptide pull-down in both experiments
(Table S1). We found that Myosin Va, Myosin light chain 6, and
DrebrinE bound to the phospho-peptide with higher efficiency
than nonphosphorylated peptide (Figure 6B).
To verify the phospho-specific binding between the TAO1/2
T440/T475 site and Myosin Va, we incubated lysates from
HEK293 cells expressing GFP alone or GFP tagged Myosin
Va-globular tail domain (GTD) with lysates from cells expressing
either TAO1-HA or TAO1-T440A-HA. Immunoprecipitation using
an anti-GFP antibody followed with western blot of the bound
proteins with HA antibody revealed that TAO1-HA, but not
TAO1-T440A-HA could bind Myosin Va (Figure 6C). Similar
coimmunoprecipitation experiments using Drebrin-GFP did not
confirm binding between TAO1-HA and Drebrin-GFP (data not
shown). To test if endogenous TAO1 or TAO2 can bind endoge-
nous Myosin Va, we immunoprecipitated Myosin Va from
Figure 5. MST3 Is Necessary and Sufficient to Phosphorylate Thousand and One Amino Acid1/2 at T440/475
(A) pTAO1/2 signal is increased when MST3-HA is coexpressed with wild-type TAO2, but not with TAO2-A (T475A). Expressed TAO2 migrates at two separate
bands at 140 kDa and 200 kDa in this experiment, although the expected size is 140 kDa.
(B) TAO2WT or TAO2A is transfected in HEK293T cells together with MST3 shRNAs targeting humanMST3 or a control shRNA. TAO2 phosphorylation at T475 is
reduced whenMST3 is knocked down in lanes three and five when compared to control in lane one, suggesting thatMST3 is necessary for T475 phosphorylation.
As expected, pTAO1/2 antibody does not detect any signal when TAO2A is expressed in lanes two, four, and six.
(C) MST3 shRNA causes reduction of phosphorylated TAO1/2 440/475. Hippocampal neurons expressing control shRNA or MST3shRNA with GFP are stained
with phosphoTAO1/2 antibody (red). Scale bar represents 20 mm.
(D) Quantification of phosphorylated TAO1/2 in cell body is significantly reduced in MST3 shRNA (n = 3 experiments each).
(E) MST3 and phosphoTAO1/2 440/475 costaining is shown. Scale bar represents 20 mm.
(F) Expression of TAO1, TAO2, and MST3 in brain lysates during development.
(G) TAO1/2 shRNA expressing layer 2/3 neuron basal dendrites in vivo (via in utero electroporation) at P20 is shown. Scale bar represents 5 mm.
(H) Quantification of spine density in neurons expressing GFP, MST3 shRNA, and TAO1/2 shRNA (n = 4, 3, and 3 animals and 19, 14, and 13 neurons,
respectively). All error bars reflect SEM. See also Figure S5.
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Figure 6. Myosin Va Interacts with Thousand and One Amino Acid1/2 upon Its Phosphorylation by MST3
(A) Schematic representation of SILAC experiment with peptide pull-down. Hippocampal neurons were cultured in SILACmedia containing either medium heavy
(Lys4 Arg6) or heavy (Lys8 Arg10) amino acids from plating to DIV9 when they were harvested. Protein lysates were incubated with beads attached with 17 amino
acids long peptides containing TAO1/20s MST3 phosphorylation site, either in phosphorylated and nonphosphorylated forms. Proteins bound to the peptides
were digested and identified in MS.
(B) There were two separate experiments where SILAC labels that were switched are plotted with respect to each other. Higher values in positive y axes and
negative x axes represent enriched binding of proteins to phospho-peptide. The proteins enriched at values >1 in both experiments are circled by a dotted line.
Myosin Va was enriched >2 in both experiments (see Table S1 for all values).
(C) GFP immunoprecipitation of Myosin Va-GTD-GFP, labeled as Myosin Va-GFP, after incubation with lysates expressing TAO1-HA wild-type and TAO1-HA
T440A mutants, reveal that only TAO1WT and not TAO1A can bind (coimmunoprecipitate) Myosin Va-GTD-GFP.
(legend continued on next page)
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MST3 Phosphorylates TAO1/2 for Spine Formationdissociated hippocampal neurons at DIV6 and found thatMyosin
Va can bind TAO1 and phosphoTAO1/2 specifically (Figure 6D),
while we were not able to detect a signal with TAO2 anti-
body (data not shown). Thus, MST3 phosphorylates TAO1 and
TAO2, enabling their association with Myosin Va.
Myosin Va Recruitment to Dendrites Is Enhanced by
Thousand and One Amino Acid1/2
Myosin V has been implicated in spinemorphology and a-Amino-
3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) type
glutamate receptor trafficking (Correia et al., 2008; Lise´ et al.,
2006; Wang et al., 2008). To test for TAO1/2 involvement in
Myosin Va function, we transfected cortical neurons at DIV13
with GFP tagged Myosin Va-GTD, a second plasmid (pLentiLox
3.7) coexpressing membrane tagged Td-tomato to visualize
neuronal membrane, and shRNA targeting TAO1/2, and imaged
at DIV16 after fixation. Myosin Va-GTD-GFP accumulated in the
dendrites in punctate pattern (Figure 6E, top row, n = 8 neurons).
Upon TAO1/2 shRNA expression, the dendritic Myosin Va-
GTD-GFP distribution was disrupted in nine out of ten neurons
(Figure 6E, bottom row) (p < 0.001 chi-square). Myosin Va-
GTD-GFP can still be localized to axons in TAO1/2 shRNA
neurons (Figure S6F), indicating that dendritic localization is spe-
cifically altered in the absence of TAO1/2.
To test if TAO1/2 knockdown affects specifically Myosin Va,
we transfected cortical neurons with HA tagged Myosin Va-
GTDor HA taggedMyosin Vb-GTD together with vector express-
ing GFP alone or GFP with TAO1/2 shRNA (Figure S6), and
immunostained these neurons with an anti-HA antibody (red).
Myosin Va-HA was found in dendrites in eight out of ten neurons
coexpressing GFP, whereas TAO1/2 knockdown in all 11 neu-
rons reduced Myosin Va in dendrites (Figures S6A and S6C,
p < 0.001 chi-square). Unlike Myosin Va, Myosin Vb-GTD puncta
accumulated in the perinuclear region of control neurons (Fig-
ure S6B, arrow, n = 12 neurons). Interestingly, TAO1/2 knock-
down caused Myosin Vb-HA puncta to appear in dendrites in
12 out of 13 neurons (Figures S6B and S6D, p < 0.001 chi-
square). Thus, TAO1/2 facilitates dendritic localization of Myosin
Va, and knockdown of TAO1/2 results in an increase of Myosin
Vb in dendrites, possibly via a compensatory upregulation.
Moreover, Myosin Va-GTD-GFP puncta colocalized with endog-
enous Rab11 (Figure S6E), indicating thatMyosin Va could be re-(D) Endogeneous Myosin Va is immunoprecipitated using an antibody from diss
show that endogeneous TAO1 and phosphoTAO1/2 are immunoprecipitated by
(E) MyosinVa-GTD-GFP distribution in dendrites is altered upon TAO1/2 shRNA
microscopy without amplification via immunostaining. Z projections are shown. Td
Td-tomato. TAO1/2 shRNA is also expressed on the same plasmid at a differen
expressing empty vector showed the showed punctate Myosin Va-GTD-GFP in d
as depicted in lower panel n = 9 out of 10. Scale bars represent 25 mm.
(F) Myosin Va-GTD-GFP is coexpressed with either wild-type or T440A mutant
Va-GTD-GFP (arrows). Scale bar represents 10 mm.
(G)Myosin Va-GTD-GFP accumulation in cell bodywhen compared to dendriticM
neurons. Total cell body Myosin Va-GTD-GFP intensity is measured in z projec
puncta were outlined individually, total intensity was measured and normalized to
between cell body/dendritic Myosin Va intensity is shown for TAO1-wt and TAO
(H) Signaling pathway identified. MST3 phosphorylates several substrates particu
TAO1/2, upon phosphorylation Myosin Va containing complex can bind TAO1/2.
reflect SEM. See also Figure S6.cruited to recycling endosomes, where its function could be
required for dendritic spine formation.
To find out if the T440 residue of TAO1 is important for the
dendritic localization of Myosin Va-GTD-GFP, we expressed
TAO1wild-type (WT) or TAO1 T440A mutant together with
Myosin Va-GTD-GFP in dissociated cortical neurons at DIV13
and imaged at DIV16. TAO1WT and TAO1A colocalized with
Myosin Va-GTD-GFP (Figure 6F), in contrast to the diffuse cyto-
plasmic staining in GFP expressing control neurons (Figure S4A).
By taking the ratio of the normalized Myosin Va-GTD-GFP signal
in the cell body and that in a primary dendrite, we found that
Myosin Va-GTD-GFP is enriched in the cell body in TAO1A ex-
pressing neurons when compared to TAO1WT expressing neu-
rons (Figure 6G, n = 7 and 8 neurons in TAO1WT and TAO1A,
respectively). Thus, while there might be other proteins that
enable Myosin Va and TAO1 to be found in the same complex,
T440 phosphorylation is critical in enabling dendritic localization
of a larger percentage of Myosin Va. In summary, not only does
Myosin Va associate with TAO1/2 kinase, but its localization is
also altered by TAO1/2 function and phosphorylation state,
which in turn is dependent on MST3 kinase, as depicted in
Figure 6H.
DISCUSSION
In this study, we examine MST3 kinase signaling by identifying
multiple potential substrates, mostly cytoskeletal regulators. In
particular, the TAO1/2 kinase upon phosphorylation by MST3
on site T440/T475 associates with Myosin Va in a phosphoryla-
tion dependent manner, and this phosphorylation promotes
Myosin Va recruitment in dendrites. Thus by using chemical
genetic techniques, we have uncovered a kinase signaling
cascade that functions in neuronal dendritic spine and synapse
formation.
Role of MST3 in Dendrite, Dendritic Filopodia, and Spine
Development In Vitro and In Vivo
By expressing MST3 shRNA or KD MST3 in cultured hippocam-
pal neurons, we show MST3 is required for limiting dendritic
filopodia andmaintaining dendritic spine and excitatory synapse
structure. Whereas the MST3 shRNAs used in our study target
regions common to MST3a and MST3b, expression of theociated hippocampal neurons protein lysates (at DIV6 or DIV9). Immunoblots
endogeneous Myosin Va.
expression in cortical neurons. Myosin Va-GTD-GFP is imaged by confocal
-tomato is expressed pLentiLox3.7 (empty vector) in which GFP is replaced by
t promoter. Images are captured with same settings. N = 8 out of 8 neurons
endritic arbor. Neurons expressing TAO1/2 shRNA lacked dendritic distribution
TAO1-HA in cortical neurons. TAO1 (HA staining) is colocalized with Myosin
yosin Vawas lower in TAO1-WT expressing neurons than in TAO1-A expressing
ted images and normalized per area after background subtraction. Dendritic
total puncta area and dendritic length (30 mm dendrite was included). Ratio
1-A (n = 7 and 8 neurons, respectively) (p < 0.01).
larly actin and microtubule binding/regulating proteins. MST3 phosphorylates
TAO1/2 function is critical for Myosin Va localization to dendrites. All error bars
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MST3 Phosphorylates TAO1/2 for Spine Formationshorter MST3a isoform is sufficient for rescuing the shRNA
effects. MST3b has distinct functions in axonal growth, which
could be due to possible specific subcellular localization or inter-
actions. Using pan-MST3 antibody raised against a common
epitope of MST3a and MST3b, we observed a mostly dendritic
and perinuclear staining for MST3 (Figure 1), which overlaps
with phosphoTAO1/2 staining (Figure 5E) and supports their
function for dendritic filopodia and spine development. MST3
is also implicated in radial neuronal migration (Tang et al.,
2014). Our in vivo analyses using in utero electroporations at
E14.5 showed a majority of electroporated neurons in upper
layers at P20. Hence, we focused on spine development on layer
2/3 neuron basal dendrites.
MST30s Phosphorylation Substrates
Notwithstanding its broad expression pattern and its functions
in apoptosis and axonal growth, little is known about the phos-
phorylation targets of MST3 except for NDR1 kinase (Stegert
et al., 2005). By using the covalent capture method as an unbi-
ased screen that can use complex proteinmixtures as the source
of substrates and can also identify the phosphorylation site
(Hertz et al., 2010; Ultanir et al., 2012), we identified 13 phos-
phorylation targets of MST3, as well as a consensus motif for
MST3 phosphorylation.
Several of the candidate MST3 substrates identified in this
study implicate MST3 in regulating the cytoskeleton (Table 1).
Among these candidates, we chose TAO1/2 for further study
(see next section), and the rest are briefly discussed here.
EPS8 is an actin capping protein (Menna et al., 2009) originally
identified as a phosphorylation target of the epidermal growth
factor receptor. Interestingly, EPS8 positively regulates spine
formation and maturation and negatively regulates filopodia
(Menna et al., 2013; Stamatakou et al., 2013), in agreement
with our finding that the EPS8 phospho-mimetic form reduces
filopodia formation. The lack of effect of EPS8 shRNA in hippo-
campal neuronal cultures could be due to the potential pres-
ence of its homologs EPS8L, EPS8L2, and EPS8L3. Several
potential MST3 substrates could contribute to the regulation
of dendritic actin cytoskeleton: Arhgap18 is a Rho-GTPase acti-
vating protein (GAP) (Maeda et al., 2011), PAK6 is an effector
of the Rho family GTPases, and Formin-like protein 2 (FMNL2)
is an actin binding protein that can bind and bundle actin fila-
ments (Scho¨nichen and Geyer, 2010). In addition, we identified
two oligodendrocyte-specific cytoskeleton regulators, namely
TPPP/p25alpha (Song et al., 2007) and Ermin (an actin binding
protein) (Brockschnieder et al., 2006), as putative MST3 sub-
strates, further implicating MST3 in cytoskeletal regulation in
oligodendrocytes.
There were two of the putative substrates, GIPC and Tsg101,
that suggest a role for MST3 in the regulation of membrane
trafficking. GAIP interacting protein, C terminus (GIPC) is a
PDZ domain containing protein, which regulates trafficking of
membrane proteins including N-methyl-D-aspartate (NMDA)
receptors in neurons (Yi et al., 2007). Tumor susceptibility gene
101 (Tsg101) is a component of the endosomal sorting com-
plex, required for ubiquitin-dependent sorting of proteins into
endosomes.
Identification of Caspase 3 as a putative MST3 substrate
is intriguing, as Caspase 3 is activated by MST3 in human tro-978 Neuron 84, 968–982, December 3, 2014 ª2014 Elsevier Inc.phoblasts (Wu et al., 2008, 2011). Whereas the MST3 phosphor-
ylation site is not conserved in human Caspase 3, a potential
phosphorylation site (T16) is found in a similar location in human
Caspase 6-beta. An interesting hypothesis is that this activation
might arise from direct phosphorylation of Caspase 3 or Cas-
pase 6 by MST3 in mice and humans, respectively.
Cystine glutamate transporter/Slc7a11, a transporter associ-
ated with glutamate toxicity in neurons, a putative substrate of
MST3, is active in both neurons and glia (Bridges et al., 2012;
Dixon et al., 2012; Jackman et al., 2012). Finally, the identifica-
tion of eukaryotic elongation factor 1a as a putative MST3 target
has implications in translational regulation.
Spine morphogenesis is regulated by NDR1/2 (Ultanir et al.,
2012). Notably, although both NDR1/2 and MST3 kinases alter
spine morphogenesis, they do so via distinct sets of putative
substrates identified by our chemical genetic screen. NDR1/20s
substrates implicate membrane trafficking regulation whereas
MST30s substrates implicate cytoskeleton regulation.
Roles of the Phosphorylation Targets of Thousand and
One Amino Acid 1 and Thousand and One Amino Acid 2
Kinases in Dendritic Filopodia and Spine Development
Expression of phospho mutant and phospho-mimetic mutant
substrates could act as dominant-negative and constitutively
active forms of the effectors, thereby resulting in phenotypes
similar to the loss or gain of function phenotypes of MST3.
Among the tested substrates, we found that TAO1 and TAO2
phospho mutants resulted in phenotypes strikingly similar to
that of MST3 loss of function. We do not rule out the involvement
of any of the other putative substrates, as not all phospho
mutants may act as dominant negatives. Our screen, however,
was useful in identifying TAO1/2 kinases as likely downstream
effectors for more in depth investigation. Using shRNA expres-
sion, we demonstrated that TAO1/2, and in particular the TAO2
activity, is required for dendritic filopodia development and
maintenance of spines. We further confirmed that MST3 is
necessary and sufficient to phosphorylate TAO1/2.
TAO1 and its homolog TAO2 are serine/threonine kinases in
the Ste20 kinase family. TAO1 is also called microtubule affinity
regulating kinase kinase, and it regulates microtubule affinity
regulating kinase (MARK/Par1) via phosphorylation (Timm et al.,
2003). MARK, in turn, phosphorylates MAPs to cause microtu-
bule breakdown (Drewes et al., 1997). Implicated in behaviors
induced by ethanol, nicotine, and cocaine, Drosophila TAO
genetically interacts with the microtubule regulator Par1 and is
required for the development of the mushroom body in the
Drosophila brain (King et al., 2011). TAO1 colocalizes with micro-
tubules in S2 cells and limitsmicrotubule growth (Liu et al., 2010).
TAO1may also form a link betweenmicrotubules and actin cyto-
skeleton by interacting with actin and microtubule binding pro-
teins (Johne et al., 2008; Mitsopoulos et al., 2003). It remains to
be determined how TAO1 functions in cytoskeleton regulation
and whether its functions depend on MST3 phosphorylation.
TAO2 is highly similar to TAO1 in its kinase domain. TAO1 and
TAO2 are expressed in the brain (Hutchison et al., 1998) and are
involved in p38 MAP kinase regulation (Chen et al., 1999; Hutch-
ison et al., 1998). Interestingly, TAO2 has also been implicated as
a candidate gene for the autism spectrum disorder (Weiss et al.,
2008), a neurodevelopmental disorder. TAO2 is localized to actin
Neuron
MST3 Phosphorylates TAO1/2 for Spine Formationcytoskeleton in dendritic growth cones in the first postnatal week
and is involved in basal dendrite development in cortical neurons
via its interaction with the semaphorin 3A receptor Neuropilin
and subsequent c-Jun N-terminal kinase activation (de Anda
et al., 2012). Arcadlin, an activity-regulated cell adhesion mole-
cule, can bind N-cadherin and a shorter splice isoform of
TAO2, TAO2b, to activate p38 MAP kinase, resulting in N-cad-
herin internalization (Yasuda et al., 2007). Actin and microtubule
often interact in cytoskeleton. Of particular interest is the regula-
tion of Myosin Va’s association in dendritic cytoskeleton as
described below.
Thousand and One Amino Acid 1/2 Binding and
Regulation of Myosin V Motors
Phosphorylation is a posttranslational modification that may
alter protein function by affecting its interaction with binding
partners. The observation that the TAO1A and TAO2A phospho
mutant expression increases filopodia density underscores
the significance of MST3 phosphorylation. We hypothesize that
these mutant kinases might be binding and titrating components
of TAO1/2 signaling, thus acting as a dominant negative.
Using a SILAC based immunopreciptation method, we identi-
fied a protein complex includingMyosin Va, Myosin light chain 6,
and DrebrinE that bind peptides bearing the TAO1/2 phos-
phorylation site in a phosphorylation dependent manner. Unlike
TAO1WT, TAO1A is unable to bind Myosin Va. We further
confirmed the phosphospecific binding of Myosin Va to TAO1/
2 via coimmunoprecipitation. Moreover, endogenous Myosin
Va can bind endogenous TAO1 and phosphorylated TAO1/2 in
neurons.
Myosin Va is an abundant protein in the brain and is present in
synaptic fractions (Walikonis et al., 2000). An unconventional
actin motor protein, Myosin Va in vertebrates can tether cargo
to actin cytoskeleton at the cell periphery (Wu et al., 1998);
reduce microtubule based transport when recruited on the
same cargo with the microtubule motor kinesin (Kapitein et al.,
2013); and perform short-range transport of cargo on actin fila-
ments (Hammer and Sellers, 2012; Kapitein et al., 2013). In hip-
pocampal neurons, both Myosin Va (Correia et al., 2008) and
Myosin Vb (Lise´ et al., 2006; Wang et al., 2008) are implicated
in trafficking of AMPA type glutamate receptors into dendritic
spines, although previous studies showed no defects in basal
or plasticity induced AMPA receptor recruitment to synapses
in Myosin Va mutant mice Dilute-Lethal (Petralia et al., 2001;
Schnell and Nicoll, 2001). Myosin Va is also implicated in trans-
porting endoplasmic reticulum in Purkinje neuron dendritic
spines (Wagner et al., 2011). Myosin Va knockdown in neuronal
cultures drastically reduces spine density (Lise´ et al., 2009). A
recent examination of the Myosin Va neurological mutant mice
flailer, which express a dominant-negative Myosin Va fusion pro-
tein lacking the actin binding domain, revealed a reduction of
mature dendritic spines and an increase in dendritic filopodia
(Yoshii et al., 2013). In these mutant mice, the mature excitatory
synaptic markers PSD-95, stargazin, the endocytic zone marker
Dynamin 3, and AMPA receptors are drastically mislocalized to
dendritic shaft (Yoshii et al., 2013). These data support the notion
that Myosin Va is critical for mature spine synapse formation.
Interestingly, despite the loss of mature spine synapses in flailer
mice, the AMPA receptor currents are increased (Yoshii et al.,2013). Our observation of increased Myosin Vb trafficking to
dendrites in the absence of TAO1/2 and dendritic Myosin Va is
indicative of a compensatory Myosin Vb function in the absence
of Myosin Va.
We find that Myosin Va-GTD is localized in a punctate pattern
along the dendrites and colocalizes with the recycling endosome
marker Rab11, and we show that this recruitment is dependent
on TAO1/2 function. Membrane transport from recycling endo-
somes is required for maintenance of dendritic spine structure
as well as for delivery of AMPA receptors during synaptic plas-
ticity (Park et al., 2006). TAO1 colocalizes with Myosin Va-GTD
independent of its T440 phosphorylation, implicating a mecha-
nism for recruitment of TAO1 into Myosin Va complexes that is
distinct from their interaction via the T440 region. Interestingly,
TAO1A shifts Myosin Va distribution from dendrites to neuronal
cell body, suggesting that the T440 site on TAO1 is important
in regulating TAO1 function and dendritic localization of Myosin
Va in controlling spine development.
The opposite effects of TAO1/2 shRNA knockdown on the
expression of Myosin Va and Myosin Vb could reflect a homeo-
static response to the reduction of Myosin Va. How TAO1/2
regulates Myosin Va remains an open question. A possibility is
that TAO1/2 regulates Myosin V motor function by binding and
phosphorylating components of the Myosin Va complex, and
enhancing its dendritic localization.
Chemical Genetics for Kinase Substrate Identification
A chemical genetic screen for kinase substrate identification is
an unbiased method to identify substrates in relatively intact
protein lysates without the need for peptide arrays or gel elec-
trophoresis. The combination of simple chemistry to highly
enrich for peptides of substrates phosphorylated by a kinase
of interest, and the ability to identify the substrates as well as
the phosphorylation sites by using powerful liquid chromatog-
raphy/tandem mass spectrometry renders this technique
uniquely advantageous for studying downstream effectors of
kinases.
Phosphorylation often alters protein function by changing
binding properties of substrates. We have now added a further
technical advance to the kinase substrate identification screen
through which we can determine the phosphorylation state
dependent protein interactors that bind the substrates on the
phosphorylation sites. Using a quantitative, unbiased peptide
pull-down screen approach, which can be achieved by SILAC la-
beling of proteins in neuronal cultures, we were able to identify
protein interactors of TAO1/2 that critically depend on their
MST3 phosphorylation site. We believe our methodology of
chemical genetic kinase substrate identification, followed by
determining the functionality of the phosphorylation is a useful
paradigm in delineating kinase signaling.
EXPERIMENTAL PROCEDURES
Neuronal Cultures, DNA Constructs, Small Hairpin RNA, and
Lentiviruses
Hippocampal neurons were cultured from E19 Long-Evans rats (Charles River
Lab) in accordance with local guidelines at the University of California San
Francisco (UCSF) and National Institute for Medical Research as described
before (Ultanir et al., 2012). Mouse MST3 (BC004650) cDNA purchased from
ATCC was cloned in pRK5 mammalian expression vector with N-terminalNeuron 84, 968–982, December 3, 2014 ª2014 Elsevier Inc. 979
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expression vector was a gift from Dr. Froylan Calderon De Anda and Dr. Li-
Huei Tsai from the Massachusetts Institute of Technology (de Anda et al.,
2012). Human FMNL2, human ArhGAP18, mouse GIPC, mouse EPS8, human
TAO1, and human PAK6 were purchased from Thermo Scientific and cloned
into pRK5 vector with N-terminal HA tag. Mutations were generated by site
directedmutagenesis. Myosin Va-GTD-GFP, Myosin Va-GTD-HA, andMyosin
Vb-GTD-HA vectors were gifts from Dr. Don Arnold from the University of
South California (Lewis et al., 2009).
All shRNA sequences were 19 base pairs long and were selected via http://
katahdin.cshl.org/html/scripts/main.pl. Hairpins targeting these sequences
were cloned in pLentiLox 3.7, which expresses EGFP via a separate promoter
in addition to expressing shRNA via a U6 promoter. Lentiviruses were gener-
ated at UCSF core facilities. All clones were verified by sequencing.
In Utero Electroporation
In utero electroporation surgery was performed in accordance with local
guidelines as described (Ultanir et al., 2012). Embryos were injected with
1 mg/ml pCAG-GFP (control), or 0.4 mg/ml pCAG-GFP + 1 mg/ml MST3 shRNA
#1, or 0.4 mg/ml pCAG-GFP + 1 mg/ml TAO1/2 shRNA. Mice were perfused at
P18–P20 using 4% paraformaldehyde and 4% sucrose.
Antibodies and Confocal Microscopy
For a detailed list of antibodies and dilutions, please see Supplemental Experi-
mentalProcedures.Dendriteswere imagedusingan invertedLeicaSP5confocal
microscopeusinga633 (NA1.4)objectiveat63 zoom.Zsectionswereobtained
across the dendrite depth at 0.5 mmz intervals. Spine density and categorization
was done manually using Leica image analysis. Spine head diameter measure-
ments were done using a custom plugin in ImageJ (Ultanir et al., 2007).
Mammalian Sterile 20-like Kinase 3 Kinase Assays
HA tagged MST3 was expressed in COS7 or HEK293T cells for 48 hr before
purified via HA epitope tag using Anti-HA Affinity matrix (Roche, clone 3F10).
Kinase assays were conducted in 20 mM Tris-HCl pH 7.5, 10 mM MgCl2,
1 mM dithiothreitol (DTT), 100 mM ATP, 13 Phosphatase inhibitor cocktail, and
0.5mMof anATPanalog for 30minat 30C.Reactionwas followed byalkylation
for 1 hr at room temperature by addition of 2 ml 100mMPNBMper30ml of kinase
reaction.
Mammalian Sterile 20-like Kinase 3 Substrate Labeling and
Identification
Kinase substrate labeling was done in P3 and P13 mouse brain lysates
obtained as described (Ultanir et al., 2012). Purified MST3-MG and MST3-
KDwere used for labeling. Covalent capture method for kinase substrate iden-
tification and mass spectrometry was done as previously described (Ultanir
et al., 2012).
Multiplex Stable Isotope Labeling by Amino Acids in Culture
Labeling of Neuronal Cultures and Phospho-Peptide Pull-Down
Cortical neuronal cultures were labeled using Multiplex SILAC (Zhang
et al., 2011), and peptide pull-downs using SILAC labeled lysates was con-
ducted as described (Stephanowitz et al., 2012). TAO2 T475 peptide (C
RNRDHFAT*IRTASLVSR) was synthesized with or without a phosphorylation
at the indicated threonine and conjugated to iodoacetyl agarose. Precipi-
tated proteins were subjected to in-bead typsin digest followed by
reversed-phase liquid chromatography-electrospray tandem mass spec-
trometry (LC-MS/MS) analysis.
Immunoprecipitations
HEK293T cells transfected with Myosin Va-GTD-GFP, control GFP construct,
HA-TAO1, and HA-TAO1A, separately. Lysate from Myosin Va-GFP or con-
trol GFP transfected cells was incubated with Protein G beads prebound
with monoclonal GFP antibody, and then lysates from either HA-TAO1 or
HA-TAO1A transfected cells were added and incubated with the beads con-
taining Myosin V-GFP or GFP alone. For immunoprecipitation from neurons
precleared lysates fromDIV6 or DIV9 rat hippocampal neurons were incubated
with Myosin Va antibody bound Protein A beads (Sigma) overnight at 4C.980 Neuron 84, 968–982, December 3, 2014 ª2014 Elsevier Inc.SUPPLEMENTAL INFORMATION
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